Jean-François Millau is the co-founder and CEO of TATUM bioscience. He is a scientist-entrepreneur at heart who holds a PhD in Biotechnology and is a Grenoble Business School graduate. He has authored numerous publications on cancer research, holds several patents, and pioneered the development of the first biochip to measure DNA repair activities. Convinced that synthetic biology will revolutionize immuno-oncology, he co-founded TATUM bioscience to develop radically new immunotherapies to outwit cancer.